NEW YORK – The US Food and Drug Administration issued a letter on Monday alerting clinical labs and healthcare providers about two concerns related to a COVID-19 test from Thermo Fisher Scientific.
NEW YORK – The US Food and Drug Administration issued a letter on Monday alerting clinical labs and healthcare providers about two concerns related to a COVID-19 test from Thermo Fisher Scientific.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.